Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

Background<br/> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine...

Full description

Bibliographic Details
Main Authors:	Henriques, G, Phommasone, K, Tripura, R, Peto, T, Raut, S, Snethlage, C, Sambo, I, Sanann, N, Nguon, C, Adhikari, B, Pongvongsa, T, Imwong, M, von Seidlein, L, Day, N, White, N, Dondorp, A, Newton, P, Ley, B, Mayxay, M
Format:	Journal article
Published:	BioMed Central 2018

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

Similar Items